Trending...
- Top US Investors Rank Bitmagic Hottest Game Changer in Generative AI 2025
- Last Chance for Green Card Dreams: DV Lottery Deadline Extended to November 7
- iGolf Announces Renewed Partnerships with Leaderboard and Beezer Golf
LOS ANGELES - Californer -- Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of acute myocardial infarction (AMI), commonly known as a heart attack, is essential for improving patient outcomes and reducing mortality rates. However, the high costs and infrastructure requirements associated with traditional laboratory-based diagnostic equipment often limit access to high-quality care, particularly in low- and middle-income regions.
To address this challenge, UCLA researchers developed a high-sensitivity vertical flow assay (hs-VFA) that combines the precision of traditional laboratory testing with the convenience and affordability of point-of-care technologies. Their findings demonstrate that this innovative platform can accurately quantify cTnI levels in just 15 minutes using a small sample of serum, making it ideal for rapid diagnostics in emergency settings or remote locations.
More on The Californer
The core of this platform lies in the integration of deep learning algorithms with cutting-edge nanoparticle amplification chemistry. The hs-VFA system uses time-lapse imaging and computational analysis to enhance the detection of cTnI—a key biomarker for cardiac damage—achieving a detection limit as low as 0.2 picograms per milliliter (pg/mL). This level of sensitivity surpasses current point-of-care devices by a significant margin and meets the clinical requirements for high-sensitivity troponin testing, which is essential for the early diagnosis of AMI.
In rigorous testing using both spiked and clinical serum samples, the hs-VFA demonstrated high precision with a coefficient of variation (CV) of less than 7%. It also exhibited a strong correlation with gold-standard laboratory analyzers. Importantly, the hs-VFA also demonstrated an extensive dynamic range, covering cTnI concentrations from 0.2 pg/mL to 100 nanograms per milliliter (ng/mL). This range makes it suitable not only for diagnosing heart attacks but also for monitoring at-risk patients over time.
More on The Californer
The paper-based assay costs less than $4 per test, while the portable reader, designed using a Raspberry Pi computer and off-the-shelf components, costs approximately $170 per unit. This affordability is crucial for expanding access to high-quality diagnostics in low-resource settings, where traditional laboratory infrastructure may be unavailable.
Beyond cardiac diagnostics, the researchers believe the hs-VFA platform could be adapted for other critical low-abundance biomarkers, broadening its potential applications to various areas of medical diagnostics. The portability, simplicity, and affordability of the platform position it as a viable alternative to centralized laboratory testing for many conditions, offering hope for improved health outcomes on a global scale.
This research was supported by the US National Science Foundation (NSF) PATHS-UP Engineering Research Center.
Publication: https://pubs.acs.org/doi/10.1021/acsnano.4c05153
To address this challenge, UCLA researchers developed a high-sensitivity vertical flow assay (hs-VFA) that combines the precision of traditional laboratory testing with the convenience and affordability of point-of-care technologies. Their findings demonstrate that this innovative platform can accurately quantify cTnI levels in just 15 minutes using a small sample of serum, making it ideal for rapid diagnostics in emergency settings or remote locations.
More on The Californer
- Long Beach: El Dorado Nature Center to Host California Native Plant Sale November 5-26
- Tech Developers Poised to Shape Political Landscape in 2024 Election
- Los Angeles Auto Show 2024 to Offer Consumers Unmatched Range of Test Ride-and-Drive Experiences
- Global Uproar Over Violations of Religious Freedom and Rising Intolerance
- Two New Members Join The Ventura College Foundation Board
The core of this platform lies in the integration of deep learning algorithms with cutting-edge nanoparticle amplification chemistry. The hs-VFA system uses time-lapse imaging and computational analysis to enhance the detection of cTnI—a key biomarker for cardiac damage—achieving a detection limit as low as 0.2 picograms per milliliter (pg/mL). This level of sensitivity surpasses current point-of-care devices by a significant margin and meets the clinical requirements for high-sensitivity troponin testing, which is essential for the early diagnosis of AMI.
In rigorous testing using both spiked and clinical serum samples, the hs-VFA demonstrated high precision with a coefficient of variation (CV) of less than 7%. It also exhibited a strong correlation with gold-standard laboratory analyzers. Importantly, the hs-VFA also demonstrated an extensive dynamic range, covering cTnI concentrations from 0.2 pg/mL to 100 nanograms per milliliter (ng/mL). This range makes it suitable not only for diagnosing heart attacks but also for monitoring at-risk patients over time.
More on The Californer
- California: Governor Newsom sues Norwalk for unlawful homeless shelter ban
- Simi Valley Family YMCA Forms New Advisory Board
- Bosco Tech Fall Open House is November 17
- California: Governor Newsom statement on passing of Quincy Jones
- California Credit Union Launches Annual Holiday Toy Drive With Los Angeles Boys & Girls Club
The paper-based assay costs less than $4 per test, while the portable reader, designed using a Raspberry Pi computer and off-the-shelf components, costs approximately $170 per unit. This affordability is crucial for expanding access to high-quality diagnostics in low-resource settings, where traditional laboratory infrastructure may be unavailable.
Beyond cardiac diagnostics, the researchers believe the hs-VFA platform could be adapted for other critical low-abundance biomarkers, broadening its potential applications to various areas of medical diagnostics. The portability, simplicity, and affordability of the platform position it as a viable alternative to centralized laboratory testing for many conditions, offering hope for improved health outcomes on a global scale.
This research was supported by the US National Science Foundation (NSF) PATHS-UP Engineering Research Center.
Publication: https://pubs.acs.org/doi/10.1021/acsnano.4c05153
Source: ucla ita
Filed Under: Medical
0 Comments
Latest on The Californer
- Golden State Lifeguards Partners with Las Vegas-Based SEMS Medics
- William "Will" Yorgey Joins Kokomo Realty in Flagler Beach, FL
- Secure Your Crypto with the Top-Rated Wallets: Compare Your Savings Options
- HIZON INTERNATIONAL FOUNDATION Unveils Scholarships for Single Mothers and Teacher Grants
- Presidential Candidate Alandar Lee Pulliam Jr Confronts Voter Fraud: "Voter ID is Essential for Elec
- Alandar Lee Pulliam and Abel Fuentes Launch AyeStack Records and Music Publishing: A Groundbreaki
- California: Governor Newsom proclaims Native American Heritage Month
- California: Governor Newsom takes action to support communities recovering from fires
- Bruxie Brings Waffle Sandwiches and Fried Chicken Tenders to Two LA College Communities
- Mix Engineer Rob Chiarelli Has Another Top #10 Hit With "Try Love"
- Join the Exclusive Webinar on AI Transformation in Real Estate Financing
- California: Governor Newsom reaches agreement with La Habra Heights on violations of state housing law
- Never-Before-Seen Kamala Harris and Ady Barkan Interview Released on Anniversary of Barkan's Passing, Just Ahead of Election Day
- City of Long Beach to Host Community Meetings for Orange Avenue Backbone Bikeway Project
- Hoodgeek Merges Pov Commentary On Culture, Entertainment, Politics, Music, Sports, And Technology
- Boot Scootin' for Scholarships: A Night of Music, Dancing, and Giving Back!
- Author Kimberly Otte Lifts the Veil of Shame in New Book 'Breaking My Silence' to Empower Survivors
- A Christmas Carol Tradition Continues At Cygnet Theatre With New Twists
- City of Long Beach Implements Community Technology Pilot Projects in Willmore, Westside, Ramona Park and Hamilton Neighborhoods
- Author Details the Towering Challenges Facing the Harris White House